2020

  • DATABASE (138)

  • ARTICLES (396)

    • DATABASE (138)
    • ARTICLES (396)
  • Sort by
    • Relevance
    • Date

E²JDJ was founded in New Orleans in 2020 with an agtech and foodtech focus, including in the areas of cellular agriculture and synthetic biology. It has six startups in its portfolio and makes diverse investments. Its most recent disclosed investment was in the $4.7m July 2021 seed funding round of NovoNutrients, the US-based biotech producer of alt-protein from fermentation using CO2 and other emissions.

Bånt AB is the investment vehicle of Karl Sverker Forsén based in Luleå, a coastal city in Swedish Lapland. In May 2020, the Swedish family office invested in a Gothenburg startup Mycorena, a biotech that produces mycoproteins through fermentation. The fungi-based protein can be used as an alt-protein ingredient instead of traditional plant-based food components.

UBS is a Switzerland-based financial institution providing banking, wealth management, and securities services. Originally established in 1862 as the Bank in Winterthur, it is the largest Swiss banking institution. UBS engages in venture capital activities as part of its investment banking services. In 2020, UBS began a partnership with venture capital firm Anthemis to launch UBS Next, a $200m fund that will invest in fintech and other tech startups.

Pablo Zamora is a biotechnologist from the University of Santiago, where he worked as a professor and research scientist until 2008. In 2009, he started his postdoctoral research on Mexico’s maize genetics at UC Davis Life Science Innovation Center. He worked there as a senior scientist and associate until 2014. In 2015, he was appointed the center’s Chief Science Officer based in Chile, a position he was in till January 2018.From 2013–2015, he also worked on various plant and microbe genomics projects as a senior scientist in Mars Advanced Research Institute. He was also an editor from 2012–2017 at the Journal of Technology Management & Innovation and worked at the non-profit PIPRA from 2010–2018 as international alliance manager in Sacramento, University of California.In 2015, he co-founded The Not Company (NotCo) based in Santiago. He was appointed CSO in February 2018, a role he led until March 2020, when he left the company to focus on a new project, AptaBuilder, a $60m program that promotes R&D for Chilean technology-based ventures. Zamora still consults as NotCo’s senior scientific advisor.

Founded in 2018, Oslo-based Katapult Ocean is the first investor focused entirely on oceantech and related startups. The VC also operates a three-month accelerator and has invested in 32 startups from 17 countries worldwide.The VC typically invests at the seed or pre-seed level but in July 2020 it completed its first Series A round of $8.5m investment in Chilean social enterprise Betterfly. Other recent investments include the pre-seed rounds of US foodtech GreenCover and Dutch offshore solar tech SolarDuck.

Nigerian investment bank and investor CardinalStone Partners was founded in 2008. It invests in enterprises with the potential to transform diverse sectors deemed to be strategic to the development of the economies in Nigeria, Ghana and other West African countries.The VC also reviews potential investments in relation to their ESG impact. CardinalStone currently has six companies in its portfolio including Nigerian gym chain i-Fitness and Nigerian fintech Appzone. In 2020, it raised $50m for a new private equity fund, CardinalStone Capital Advisers Growth Fund. 

Founded in 1904, Duke Energy is a North Carolina-based utilities company that has the objective of zero methane emissions by 2030. It occasianally invests in US tech startups looking to offset greenhouse gas emissions and has invested in four startups to date.   Its most recent investments were in the $50m 2020 Series C round of SOURCE Global (formerly Zero Mass Water), the premier off-grid drinking water production tech using solar-powered panels, and in the  2019 $5m round of energy management software producer Phoenix ET.

Founded in 2016 in Boulder, Colorado, Blackhorn specializes in startup investment in potential game-changers for industry, including construction – its top priority for investment – manufacturing, healthcare, agriculture, transportation, water and energy. It has no geographical bias and currently has 48 companies in its portfolio with two acquisitions to date. Its most recent investments include in the undisclosed $8m round of US medtech Cytovale in January 2021 and in the $20.5m December 2020 Series A round of employees compensation fintech Foresight Risk, based in Silicon Valley.

Based in Frankfurt, GreenTec Capital Partners is a German social impact investor that focuses on supporting African tech and non-tech startups. The VC plans to increase its investment portfolio to a total of 400 enterprises by 2023. Its current stake in 20 startups is estimated to be €32.5m. In 2020, GreenTec joined the pre-seed round of Nigerian online food cooperative Principally and seed round of Freshbag, a farmers’ marketplace in Cameroon. Recent investments also include AgroCenta’s seed funding in January 2021.

Facebook is a social networking platform founded by Mark Zuckerberg and partners in 2004. It is listed on the NASDAQ exchange under ticker code FB. Throughout its development it has acquired various complementary social media and networking services, such as Instagram and WhatsApp.As an investor, Facebook has invested in a wide range of companies. It invested in and later acquired virtual reality headset developers Oculus, and also invested in e-commerce enabler Meesho. In 2020, it joined Google, Tencent and other major tech investors as an investor in Gojek.

With a special interest in enterprise tech, Silicon Valley-based Omega Venture Partners has 25 startups in its portfolio and, to date, has invested from pre-seed to Series E stages. It has managed eight exits to date. Its most recent investments were in the 2020 $55m Series B round of US-based small business management platform ZenBusiness and in the February 2021 $50m Series B round of US voice transcription software Otter.ai. The investor boasts an extensive network of major corporations as advisors and partners including Google, Microsoft, Amazon, IBM, SAP and CitiGroup.  

Founded in 2011, London-based Agronomics Limited’s principal investing interest is in environmentally-friendly alternatives to the traditional production of meat, wherever they may be located. There are currently 17 companies in its portfolio, all of them in the cellular-based or plant-based protein category and sustainable food production.Its most recent declared investments have been in the March 2021 $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech, and in the December 2020 undisclosed pre-seed round of Chinese cellular foodtech CellX.

CareCapital, with offices in Hong Kong and Shangai, is a leading investor in the global oral and dental industry. The firm’s operations span clinical and education, consumers product, orthodontics, digital equipment, SaaS, distribution, and industry-specific services. Its team comprises industry experts such as dental entrepreneurs, managers, and practitioners, healthcare investors; the company’s portfolio includes companies based in North America with revenues of RMB 5bn, Europe RMB 1.5bn, and Asia RMB 3.5bn. In June 2020, the company signed strategic partnerships with SINOCERA and Hillhouse Capital to work closely in the development and growth of dental restoration.

Yingke PE was founded in 2010 and is headquartered in Shanghai. By the end of 2020, it had managed assets worth nearly RMB 50bn. In May 2021, it closed the RMB 10bn Yingke Science & Technology Innovation Industrial Fund. Over 90% of its funds come from financial institutions, state-owned enterprises and listed companies. Yingke PE has invested in more than 200 companies, focusing on biopharmaceuticals, core technology and upgraded consumption. Since its founding, the company has exited 53 projects, with an internal rate of return up to 54%.

Mehak Mumtaz grew up in Pakistan and decided to study biochemistry when she saw her brother suffering from an unknown learning disability. Her parents, both medical doctors, could not get an accurate diagnosis for their son.  In her search to understand the molecular mechanisms behind diseases, she applied to study at the University of Oxford. In 2008, she was granted the Reach Oxford Scholarship and graduated with a master’s in biochemistry in 2012. In 2015, the St Hilda’s alumna worked as an undergraduate tutor at Oxford while completing a PhD in pathology, specializing in oncology and cancer biology.In 2018, she worked on a rare cancer project as EIT Health Business Innovation fellow for a year. She left academia and joined a three-month bioentrepreneur bootcamp in Munich and a one-month Lev8 Woman Program at her alma mater’s Oxford Foundry. She joined EY-Parthenon in London as a strategy consultant in April 2019.In 2019, Mumtaz also met the iLoF co-founding team at the EIT Health Wild Card venture-building program. iLoF is a medtech startup that focuses on personalized medicine through the use of AI and photonics to create optical fingerprints in a cloud-based library to gather and manages disease biomarkers and biological profiles.She joined iLoF as COO and co-founder in December 2019 and left her full-time consultancy role at EY in March 2020.

Sorry, we couldn’t find any matches for“2020”.

Your payment was not successful.

Please make sure you have entered your payment details correctly. Or try again in a few moments.

small logo

The discount code you entered is invalid

Please make sure you have entered your discount code correctly. Or try again in a few moments.

Download successful.

Your sample has been sent. Please check your email.

By accessing and using www.compasslist.com and all pages within the domain (the “Website”), You accept and agree to have read, understood, accepted and agreed to be bound by the Terms of Use and Privacy Policy in full. If you disagree with all or any part of these Terms of Use and Privacy Policy, please do not use or continue any further use of this website. You acknowledge that you are aware that this Website contains an archive of existing content as at 31 December 2021 and is not being actively managed. We are under no obligation to update the content on this Website and, accordingly, no new content or articles will be posted to the Website after 31 December 2021.